Phone
022 6663 8000
FAX
022 6663 8120
Email
info@bluecrosslabs.com
Contact Us

K-GLIM-Trio Tablets

COMPOSITION
K-GLIM-Trio 1mg Tablets
Each Uncoated Bilayared Tablet Contains:
Metformin Hydrochloride IP (in sustained release form) 500 mg
Voglibose IP 0.2 mg
Glimepiride IP 1 mg
K-GLIM-Trio 2mg Tablets
Each Uncoated Bilayared Tablet Contains:
Metformin Hydrochloride IP (in sustained release form) 500 mg
Voglibose IP 0.2 mg
Glimepiride IP 2 mg
INDICATIONS
K-GLIM-Trio Tablets are indicated for the treatment of type 2 diabetes when diet, exercise and dual combination therapy do not result in adequate glycemic control.
DOSAGE AND ADMINISTRATION
Oral: Adults: Initiate dose with one tablet once daily, and gradually titrate to twice daily after assessing the therapeutic response. Or, as prescribed by the physician. Maximum recommended daily doses of individual ingredients: Metformin: 2 g in divided dosage. Voglibose: 1.8 mg in divided dosage. Glimepiride: 8 mg in 1 or 2 divided dosage.
HOW SUPPLIED
10 Tablets per strip.